EAC calls for coordinated response against Marburg Virus outbreak


Date Published

Marburg Vrus outbreak

East African Community Headquarters, Arusha, Tanzania, 4th October, 2024:  The East African Community (EAC) Secretariat has called for a swift and coordinated regional response to contain the ongoing Marburg Virus Disease (MVD) outbreak declared in Rwanda. The outbreak poses a serious threat to regional health security and requires urgent action from all EAC Partner States to prevent its spread across borders.

On the 27th September 2024 Rwanda’s Ministry of Health declared the Marburg Virus Disease (MVD) outbreak and as of 30th September, 2024 there were 29 confirmed cases and 10 deaths with more than 297 contacts under close monitoring and healthcare workers have been disproportionately affected. The World Health Organization (WHO) has raised concerns about the potential regional spread of the disease due to confirmed cases in districts near the borders of the Democratic Republic of the Congo (DRC), Uganda, and Tanzania.

“There is an urgent need for a coordinated regional response to contain the spread of this highly infectious virus through swift identification, isolation, and treatment of cases and enhanced screening at borders and health facilities,” said Hon. Andrea Aguer Ariik Malueth, EAC Deputy Secretary General, in charge of Infrastructure, Productive, Social & Political sectors

He called for Partner States to strengthen their public awareness and infection control protocols including handwashing, avoiding physical contact with symptomatic individuals and surveillance at borders and health facilities.  Read more on this link



Article Type

Sector

EAC, IOM, and GIZ Celebrate Completion of WASH Project and Risk Communication Efforts


Date Published

On 31 July 2024, the EAC, together with the International Organization for Migration (IOM) and GIZ, announced the successful conclusion of the Water Sanitation and Hygiene (WASH) Project in the region.
The US$2.5 million WASH project commenced in 2021 with the aim of strengthening the capacities of EAC Partner States to prevent and control the spread of COVID-19 and other infectious diseases using hygiene measures, risk communication, and community sensitization.

The three-year project has achieved remarkable milestones, including the installation and renovation of 43 fixed handwashing facilities at the Points of Entry and border hotspots of all seven Partner States, namely Burundi, the Democratic Republic of the Congo (DRC), Kenya, Rwanda, South Sudan, Uganda, and the United Republic of Tanzania. Read more



Article Type

ECDC Updates on Mpox Risk and Recommendations


Date Published

On August 16, 2024, the European Centre for Disease Prevention and Control (ECDC) published a Rapid Risk Assessment for the EU/EEA regarding the Mpox epidemic caused by monkeypox virus clade I, with no change in risk levels or recommendations. An epidemiological update on August 26, 2024, reported a total of 102,977 confirmed Mpox cases globally since monitoring began in 2022, with 219 deaths. The majority of cases are from Africa, particularly the Democratic Republic of Congo. The Africa CDC declared mpox a Public Health Emergency of Continental Security on August 13, 2024, and the WHO followed by declaring it a Public Health Emergency of International Concern on August 14, 2024. The ECDC has issued additional recommendations for Substances of Human Origin (SoHO) professionals, advising careful screening of donors from affected regions and deferral guidelines for those exposed to Mpox.
Read more here

 

 

 

 



Article Type

Sector

Tanzania has no Mpox case, says government


Date Published

As Mpox cases surge in various African countries, the government has assured the public that all measures are being taken to control the virus if cases will occur in the country. On 19th August, 2024, the Ministry of Health updated the public on the threat of Mpox outbreak following the global upsurge of cases, including in some East African countries. Due to this threat the public was advised to take recommended precautions to protect themselves and prevent the disease from entering the country. "I would like to inform you that, until now, no patient has been proven to have Mpox infection in the country. The Ministry of Health continues to take the following measures to prevent Mpox from entering the country," said the statement signed by Tanzania's Minister for Health.

Full statement here



Article Type

Sector

DRC receives first Mpox vaccines


Date Published

Kinshasa, 5 September 2024 – The Africa Centres for Disease Control and Prevention (Africa CDC) and United Nations Children’s Fund (UNICEF) are pleased to announce the arrival of the first shipment of 99,100 doses of JYNNEOS mpox vaccine. This shipment is expected to launch a critical vaccination campaign aimed at curbing the rising epidemic in the Democtratic Republic of Congo (DRC). The vaccine doses were officially received by the Minister of Health of the Democtratic Republic of Congo (DRC), Samuel Roger Kamba, alongside H.E. Dr. Jean Kaseya, the Director General of Africa CDC, the UNICEF Representative in DRC, Grant Leaity, and the Director General of Health Emergency Preparedness and Response Authority (HERA), Laurent Muschel. Read more.

 



Article Type

Sector

EAC Calls for Public Awareness to Combat Mpox Outbreak


Date Published

The East African Community (EAC) Secretariat has called on EAC Partner States to educate their citizens on protecting themselves and preventing the spread of Mpox. This follows reports from the World Health Organization (WHO) that Burundi and the Democratic Republic of Congo (DRC) are experiencing an outbreak of the viral Mpox disease. Read more



Article Type

Sector

EAC is on Alert after Ebola outbreak in DRC


Date Published

EAC is on Alert after Ebola outbreak in DRC

On 8 May, 2018, the Ministry of Health of the Democratic Republic Congo (DRC) declared an outbreak of the Ebola Virus Disease (EVD) in the Bikoro Health Zone, Equateur Province in the Western part of the country.

By 15 May, 2018 a total of 44 EVD cases (3 confirmed) had been reported with 19 deaths, including three health care workers. As of 16 May, 393 contacts had been identified and are being followed. A new confirmed case in the 1.2 million people town of Mbandaka, some 150 km away from Bikoro, increases the risk of spreading the disease.

The World Health Organization (WHO), Medecins Sans Frontieres (MSF), the International Committee of the Red Cross and other international organization are on site and supporting the DRC in the fight against the outbreak, the ninth that has occurred in the country.

Ebola is a zoonotic virus disease that is transmitted from animals to humans. Experts believe that bats are the reservoir for the pathogen. While they do not get sick, the Ebola virus causes a severe, often fatal illness in humans. It spreads in the human population through human-to-human transmission, via direct contact with the blood, secretions, organs or other bodily fluids of infected people and through contaminated surfaces and materials, such as bedding or clothing. There is no therapy yet for EVD and about 50% of people infected with the virus may die. Health workers have an increased risk due to the nature of their work that exposes them to infected people.

Five out of six EAC Partner States share borders with the DRC, and all of them maintain close trade relations with high border traffic. There are also direct flights between the DRC and individual East African Partner States. These factors have caused the EAC to be on high alert. Partner States have put safety measures in place that range from screening people arriving from DRC at the border posts for signs of the disease to alerting health personnel; enhancing diagnostic capacities at major research centres; and informing citizens of the risk and of preventive measures. To date, no cases of Ebola have been detected in the EAC region.

The EAC region has experienced a number of Ebola outbreaks in the past, and some 500 East African experts assisted in the fight against Ebola in West Africa in 2014-2016, when the disease killed more than 11,000 out of almost 30,000 infected people. These experts represent a unique pool of professionals from different disciplines, all with hands-on experience in responding to EVD outbreaks. They can be mobilised at short notice to join the common effort of preventing the disease to spread into the EAC. 

Still, the EAC Secretariat encourages the public to be vigilant and alert. People should seek medical attention when the following symptoms are observed: a sudden onset of fever, fatigue, muscle pain, headache and sore throat. This is often followed by vomiting, diarrhoea, and a skin rash. It can be accompanied by internal and external bleeding (e.g. oozing from the gums, blood in the stools). The public is also urged to continue cooperating with the health workers of their nearest health facilities by availing themselves of information about EVD. 

The EAC Secretariat commends the Partner States for their vigilance and quick and prudent response across disciplines as reflected in the One Health approach. The Secretariat will continue to monitor the situation together with the EAC Partner States to detect any occurrence of EVD in the region at the earliest possible time.


Tags


Article Type

Sector

EAC Secretariat urges Partner States to increase risk and crisis communication measures to keep out Ebola Viral Disease


Date Published

EAC Secretariat urges Partner States to increase risk and crisis communication measures to keep out Ebola Viral Disease

East African Community Headquarters, Arusha, 22 July 2019:  The confirmation of a fatal Ebola case in the Ituri province of the Democratic Republic of Congo (DRC) further increases the risk for the East African Community (EAC) region of the outbreak crossing the borders. The Ituri province is only 70 km from the South Sudanese border and even closer to the Ugandan border. The first three cases of Ebola in the EAC region were diagnosed in Uganda in June 2019 and triggered strong response measures by the Ugandan government. Trade is vibrant between DRC and the EAC region and can exacerbate the spread of the Ebola Virus Disease (EVD) due to the high mobility of people and goods. In the light of the Public Health Emergency of International Concern declared by the World Health Organization,) Dr Michael Katende, acting Head of Health at the EAC Secretariat urges the Partner States to strongly engage the communities in the border regions and traders and trade associations in risk and crisis communication measures. “This is particularly important, as most of the border line is porous and difficult to control” says Katende, “informal and formal traders need to know the risk and be able to take informed decisions to minimise it and to actively take precautions.”

EAC Partner States have put in place precautionary measures to stop the spread of EVD into the EAC region. This includes vaccinating frontline health workers, screening all travellers at points of entry including airports and training the first responders in case of an outbreak. However, these measures might not be sufficient. Dr Michael Katende, acting Head of Health at the EAC Secretariat was especially concerned about EVD spreading into South Sudan with its still rather weak health system.

The EAC Secretariat calls upon the Partner States to increase risk and crisis communication by involving community, religious and other leaders and the media in public awareness raising. At the same time, the Secretariat calls upon traders and trade associations and those travelling across the border with DRC to take extra precaution, as the EVD threat is real:

  • All people crossing the border should cooperate with immigration, health and security officials who are conducting screening at the points of entry and should strictly follow their advice.
  • Frontline health workers and members of the affected communities should accept to be vaccinated against EVD for their own protection and to help prevent the further spread of EVD.
  • People in the affected regions should avoid unnecessary ‘body to body’ contact as this is the main way of disease transmission.
  • The public should be vigilant and immediately inform the nearest health workers when spot a person with signs of EVD which are: fever, severe headache, body weakness, fatigue, diarrhea, vomiting, and unexplained haemorrhage (bleeding or bruising) from various body outlets like the nose, ears and mouth. This is particularly important along the “green border” where no screening measures are in place.

Ebola outbreak in the Democratic Republic of the Congo declared a Public Health Emergency of International Concern

https://www.who.int/news-room/detail/17-07-2019-ebola-outbreak-in-the-democratic-republic-of-the-congo-declared-a-public-health-emergency-of-international-concern


Tags


Article Type

Sector

Frequently Asked Questions and Answers on COVID-19


Date Published

Frequently Asked Questions and Answers on COVID-19

In January 2020 the World Health Organization (WHO) declared the outbreak of a new coronavirus disease in Hubei Province, China, to be a Public Health Emergency of International Concern, as there was a high risk of the 2019 Coronavirus Disease (COVID-19) spreading to other countries around the world. As of 2nd April 2020, more than 896,450 cases have been confirmed in more than 200 countries, more than 45,526 people have died from the disease, but about 135,000 have also already recovered since the outbreak started. The EAC region did not stay unaffected and has to date confirmed cases in Burundi, Kenya, Rwanda, Tanzania and Uganda. Most infected people developed only mild symptoms and the average global death rate among confirmed cases of about 4 % is low compared to that of other infectious diseases which we are facing in the region, such as HIV/AIDS, Measles or Ebola. This rate might be almost 10 times higher than average for those over 80, and much lower for those under 40. Most affected by the pandemic is less the health sector, but the economy as a whole, including trade and tourism, as main life-lines in the region.

To succeed in combating the pandemic, all sections of our society including employers and businesses – must play a role and work together. The virus that causes the Coronavirus disease (COVID-19) is a new strain that had not been identified in humans until the outbreak of the disease in 2019.

Coronaviruses (CoV) are a large family of viruses that are common in animals and cause illness in humans ranging from a mild cold to more severe diseases such as the Middle East Respiratory Syndrome (MERS-CoV) and the Severe Acute Respiratory Syndrome (SARS-CoV).

Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Other known coronaviruses are circulating in animals without causing illness in humans.

The COVID-19 outbreak has taken its toll on many countries worldwide and has caused huge economic losses with various sectors affected and impacted upon.

In the following we are providing answers to frequently asked questions regarding COVID-19:

What is a Coronavirus? Coronaviruses are a large family of viruses which occur naturally in animals and may cause illness in animals and humans. In humans, coronaviruses cause respiratory infections ranging from common colds with mild symptoms to more severe diseases such as the Middle East Respiratory Syndrome (MERS) and the Severe Acute Respiratory Syndrome (SARS). The most recently discovered virus in this family causes the Coronavirus Disease, COVID-19.

What does COVID-19 stand for? The Coronavirus Disease is a flu-like respiratory disease that is highly contagious.

What is COVID-19? The Coronavirus Disease is a flu-like respiratory disease that is highly contagious.

What are the symptoms of COVID-19? The most common symptoms of COVID-19 are fever, tiredness, and dry cough. Some patients may have aches and pains, nasal congestion, runny nose, sore throat or diarrhoea. These symptoms are usually mild and begin gradually. Some people become infected but don’t develop any symptoms and don't feel unwell. Most people (about 80%) recover from the disease without needing special treatment. Around 1 out of every 6 people who get COVID-19 becomes seriously ill and develops difficulty breathing.

Who is most at risk of catching COVID-19? All people are at risk once exposed to the virus that causes COVID 19, however, older people, and those with underlying medical conditions like high blood pressure, heart diseases and diabetes or suppressed immune systems, such as people with HIV/AIDS or cancer, are most at risk and more likely to develop serious symptoms.

Do I need to worry about my children? Cases in which children got infected have also been reported. However, children and even youths seem to be much less affected by the Coronavirus Disease than older people.

How does COVID-19 spread? The disease can spread from person to person either directly through small droplets when an infected person sneezes, coughs or exhales. Or people catch COVID-19 when they touch contaminated objects and surfaces and then touch their eyes, nose or mouth thereby transmitting the virus.

How can I prevent myself from getting infected? The best way to prevent an infection is to avoid exposure to the virus. This can be through thorough hygiene, by avoiding contact with infected people and by keeping a distance of about 6 feet to other people, as the virus spreads mainly from person-to-person and between people who are in close contact with each other. This is especially important for people who are at higher risk of getting very sick.

Which hygiene measures are effective? Clean your hands often by washing them with soap and water for at least 20 seconds, especially after you have been in a public place, or after blowing your nose, coughing, or sneezing.

  • You can also use a hand sanitiser that contains at least 60% alcohol. Rub your hands together until they feel dry.
  • Avoid touching your eyes, nose, and mouth with unwashed hands.

Should I wear a facemask to protect myself against the virus? Do not need to wear a facemask unless you are sick or are caring for someone who is sick (and they are not able to wear a facemask). Leave the masks to those who really need them.

What can I do to protect others if I am sick or have tested positive for the Coronavirus Disease? Stay home if you’re sick, except to get medical care, even if it is not yet clear if you are infected with the Coronavirus or just suffer from a common cold.

Also:

  • Cover your mouth and nose with a tissue when you cough or sneeze or use the inside of your elbow and wash it afterwards.
  • Throw used tissues in the trash.
  • Immediately wash your hands with soap and water for at least 20 seconds or clean your hands with a hand sanitiser that contains at least 60% alcohol.
  • Wear a facemask when you are around other people (e.g. when sharing a room or vehicle and before you enter a healthcare centre
  • First clean and then disinfect frequently touched surfaces daily, such as tables, doorknobs, light switches, countertops, handles, desks, phones, keyboards, toilets, faucets, and sinks.

Can someone who is released from COVID-19 quarantine still spread the disease? Someone who has been released from COVID-19 quarantine is no longer considered a risk for spreading the virus because he/she did not develop symptoms during the incubation period.

Quarantine means separating a person (or group of people) who has been exposed to a contagious disease but has not developed symptoms from others who have not been exposed, to prevent the possible spread of that disease.

Quarantine is usually established for the length of the incubation period of the communicable disease, which is the time span during which people would have developed symptoms after exposure. For COVID-19 this period is 14 days from the last date of exposure, because 14 days is the longest incubation period seen for similar coronaviruses.

How can I contribute to avoiding stigmatising people related to COVID-19? Fear and anxiety can lead to social stigma, for example, towards people who were quarantined for COVID-19. Stigma is associated with a lack of knowledge about COVID-19 and how it spreads or with gossip and myths.

You can fight stigma and help, not hurt, others by providing social support. You can counter stigma by learning and sharing facts, for example, that viruses do not target specific groups in the population.

Is there a treatment for COVID-19? There is no specific treatment for COVID-19. Don’t believe people who try to sell you remedies and promise that they will cure the disease. Viral diseases can be prevented if a vaccine is available, but they cannot be cured for example with antibiotics. However, supportive cure or treatment can ease accompanying symptoms, such as fever or cough.

Is there a vaccine against COVID-19? So far, no vaccine is available to prevent COVID-19. Patients will receive supportive care and treatment by the health workers to recovery.

Must I fear COVID 19? Every viral disease needs to be taken seriously and COVID-19 is highly contagious. Therefore, it can spread rapidly and infect many people in a short period of time. But, the symptoms of COVID-19 are in most cases mild. Many patients will never even see a doctor. With about 4 % the average death rate for COVID-19 is also rather low compared to other diseases that we are facing in the region. For comparison: The death rate for measles outbreaks of for the Ebola Virus Disease can be above 60 % and up to 100 % of people infected with Rabies will die.

Another example: In China, with a total population of more than 1,4 billion people, only about 80,000 cases of COVID-19 were confirmed.

What can I do to ensure my workplace is safe for me and my colleague? You can reduce working days lost due to illness and stop or slow the spread of COVID-19 if it arrives at your workplaces:

  • Make sure your workplace is clean including surfaces (e.g. desks and tables) and objects (e.g. telephones, keyboards). Wipe them with disinfectant regularly;
  • Encourage regular and thorough hand-washing by staff and visitors;
  • Ensure your workplace has adequate ventilation to allow fresh air to circulate (good respiratory hygiene);
  • Keep your colleagues well about COVID-19 and share any new information. But abstain from spreading rumours that have no underlying facts.

Is it safe to use public transport (Dalla Dalla or Matatu) with regard to COVID-19? Passengers in Matatus or Dalla Dallas are usually squeezed, there is no way of keeping a safe distance from a passenger who’s coughing and sneezing and to avoid contamination by droplets from his/her nose and mouth. Therefore, the use of Dalla Dallas is accompanied by a high risk of infection with COVID-19 and other infectious diseases. If at all possible use other means of transport as long as the outbreak of COVID-19 is ongoing as a preventive measure.

Can I attend the church service? This is a very personal decision. Certainly a church service involves a risk of infection as many people gather and sit and stand closely to each other. If you weighed the pros and cons carefully and come to the conclusion that attending the service is more important for you than protecting yourself against a possible COVID-19 infection then you are taking an informed decision. If you attend the service, keep as much distance from the other congregants as possible and avoid shaking hands. You can also address the risk with your pastor or priest and jointly consider how to address the current risk. If you are suffering from COVID-19 do NOT attend the service, as you will put others at high risk.

Are Africans less at risk of contracting the COVID-19 compared to other races? Many myths have started to evolve around COVID-19. One of them states that Africans are immune against the virus. Do not believe in such myths. This disease does not discriminate anybody. Already more than 35 African countries have reported confirmed cases of the COVID-19 disease, a clear sign that none is safe unless strict protective precautions are undertaken.

Does eating bush meat pose a risk for COVID-19 infections? Bush meat is discussed as the possible source of the current Coronavirus pandemic. Coronaviruses and many other pathogens occur naturally in animals. Therefore, the process of meat production from the animals to the plate needs to follow the strict hygiene rules of food safety. Meat should be inspected by the experts in charge and consumers are advised to cook or fry it thoroughly, until it is no longer raw, but well done.

Are patients who recovered from COVID-19 immune against the virus? It is still too early for a final answer. However, there is scientific evidence that a person who got infected with Covid-19 and recovers develops a certain degree of immunity against the strain of the virus that caused the infection. Scientists in China artificially infected Rhesus monkeys with COVID-19 and infected those who survived again with very high amounts of the virus. None of the re-infected monkeys fell sick again. The immune response of Rhesus monkeys is to a certain extent similar to that of humans. Therefore, experts carefully interpret the experiment to conclude that the course of a new infection in humans who recovered from COVID-19 would at least be much milder.

How safe are goods from China? Scientific experiments showed that the virus that causes COVID-19 can survive on clothes or other surfaces for some hours, depending on other factors like temperature, humidity and so on. Should goods from China have been contaminated with the virus, they travelled a long time before they arrive in the EAC region. Therefore, it is rather unlikely that the virus is still active. However, should “goods” in the local definition also include life animals and should they carry the virus, an infection would theoretically be possible. Therefore, China put into place extensive trade bans on wild and exotic animals.
Can I get COVID-19 through second-hand clothes from overseas? The virus that causes COVID-19 can survive on clothes or other surfaces for some hours, depending on other factors like temperature or humidity. However, if the second-hand clothes came from overseas, they travelled a long time and were disinfected before export as recommended by international standards. This makes it very unlikely that the virus survives in second-hand clothes. If you are still suspicious and want to be on the absolutely safe side, wash the clothes at 60 C or more with washing powder. This will safely kill the virus.

What is the difference between the average death rate among confirmed cases and the overall average death rate? According to World Health Organization estimates the average global death rate among confirmed COVID-19 cases is about 4%. The overall death rate is much lower because not all infections are confirmed by testing. Most cases, however, go uncounted because people with mild symptoms will never visit the doctor and therefore do not feature in official statistics. Death rates also depend on a range of factors like your age and general health, and the care you can access. The death rate is increasing exponentially in patients above 60 and is much higher in patients with medical pre-conditions such as diabetes, heart or lung diseases. Avoiding infections in this risk group should therefore have highest priority.


Tags


Article Type

Sector

EAC Partner States urged to educate citizens on monkeypox


Date Published

EAC Partner States urged to educate citizens on monkeypox

East African Community Headquarters, Arusha, Tanzania, 16th June, 2022East African Community (EAC) Partner States have been urged to provide necessary information for their citizens to protect themselves against monkeypox and prevent the virus from spreading.  

This follows reports by the World Health Organization (WHO) of 780 laboratory confirmed cases of monkeypox as of 2ndJune, 2022. The cases have been reported to or identified by the World Health Organization (WHO) from 27 Member States across four WHO regions that are not endemic for monkeypox virus, while Monkeypox is endemic in some African countries.  

According to the WHO, 1,392 suspected cases of monkeypox have been reported this year until mid of May in seven African countries. Out of these, 44 cases are confirmed. This is in the 4.5 months slightly less than half the number of cases reported for the whole of last year.  

According to WHO, the sudden appearance of monkeypox in multiple countries across the world indicates the virus has been spreading undetected for some time outside the West and Central African nations where it is usually found. 

“Because of the proximity of the EAC Partner States to some of the affected countries, it is important that we takeprecautionary measures to minimize its spread. It is important that people are given necessary information on the nature of the disease and how they can protect themselves and prevent the disease from spreading,” said Hon. Christophe Bazivamo, the EAC Deputy Secretary General in charge of the Productive and Social Sectors.  

“This will also help in avoiding unnecessary panic and stigmatization particularly now that people easily associate any disease outbreak to the ongoing COVID-19 pandemic,” added Hon. Bazivamo. 

The DSG further emphasized on the importance of factual risk communication to communities, that provides necessary information without causing unnecessary concern, and need for stepping up surveillance. 

Monkeypox outbreaks are not new. The virus was first discovered in monkeys in 1958, with the first human case in the African region detected in 1970. Since then, there have been multiple outbreaks of the viral disease that can spread from animals to humans but can also spread between people.  

Transmission is possible through close contact with an infected person, or objects including clothes and bedsheets as well as droplets. Symptoms typically include skin rash or lesions, fever, intense headache, muscle aches, back pain, general body weakness and swollen lymph nodes and last from two to four weeks. 

In many patients, the symptoms are moderate and clear up on their own but severe cases and even death can occur. WHO states the case fatality ratio, or the percent of people dying compared to those diagnosed, to be around 3-6 percent.  

In comparison to COVID-19, which is a highly contagious disease, transmission of monkeypox is more difficult. WHO assesses the current risk posed by monkeypox to human health and for the general public as low. 

To reduce the risk of contracting the virus, people should: 

  • Avoid coming into contact with people recently diagnosed with the virus or those who may have been infected. 
  • Wear a face mask when in close contact with someone who has symptoms. 
  • Use personal protective equipment when caring for patients with confirmed or suspected monkeypox infection. 
  • Wash hands with soap and water or use alcohol-based sanitizers, especially after coming into contact with infected or infection-suspected animals or humans.  
  • Regularly wash clothing and bedsheets at high temperature 
  • Only eat meat that has been cooked thoroughly. 
  • Avoid coming into contact with sick animals that could be carrying the virus, such as rodents or non-human primates and refrain from eating or handling so-called bush meat. 

A person who suspects to have contracted monkeypox should self-isolate him or herself from physical contact with others and seek medical advice immediately. The virus causing monkeypox belongs to the same group as the smallpox virus, however, it is a much milder and less deadly form of it.  

Vaccination against smallpox has been shown to be protective against monkeypox and a new vaccine against smallpox and monkeypox has been approved but is not yet widely available. An antiviral to treat the monkeypox virus has been recently approved in the United States of America and in the European Union. Otherwise, treatment aims to ease the symptoms and includes, for example, painkillers. 


Tags


Article Type

Sector